Literature DB >> 10608026

Pulmonary Embolism Thrombolysis Improves Survival in Massive Pulmonary Embolism.

.   

Abstract

Entities:  

Year:  1995        PMID： 10608026     DOI： 10.1007/bf01062712

Source DB:  PubMed          Journal:  J Thromb Thrombolysis        ISSN： 0929-5305            Impact factor:   2.300


× No keyword cloud information.
  6 in total

1.  Pulmonary embolism thrombolysis: a clarion call for international collaboration.

Authors:  S Z Goldhaber
Journal:  J Am Coll Cardiol       Date:  1992-02       Impact factor: 24.094

2.  The International Cooperative Pulmonary Embolism Registry.

Authors:  S Z Goldhaber; L Visani
Journal:  Chest       Date:  1995-08       Impact factor: 9.410

3.  Prognostic significance of right ventricular hypokinesis and perfusion lung scan defects in pulmonary embolism.

Authors:  M W Wolfe; R T Lee; M L Feldstein; J A Parker; P C Come; S Z Goldhaber
Journal:  Am Heart J       Date:  1994-05       Impact factor: 4.749

4.  Streptokinase and Heparin versus Heparin Alone in Massive Pulmonary Embolism: A Randomized Controlled Trial.

Authors: 
Journal:  J Thromb Thrombolysis       Date:  1995       Impact factor: 2.300

5.  Alteplase versus heparin in acute pulmonary embolism: randomised trial assessing right-ventricular function and pulmonary perfusion.

Authors:  S Z Goldhaber; W D Haire; M L Feldstein; M Miller; R Toltzis; J L Smith; A M Taveira da Silva; P C Come; R T Lee; J A Parker
Journal:  Lancet       Date:  1993-02-27       Impact factor: 79.321

Review 6.  Contemporary pulmonary embolism thrombolysis.

Authors:  S Z Goldhaber
Journal:  Chest       Date:  1995-01       Impact factor: 9.410
  6 in total
  1 in total

1.  High dose and short-term streptokinase infusion in patients with pulmonary embolism: prospective with seven-year follow-up trial.

Authors:  C Jerjes-Sanchez; A Ramirez-Rivera; R Arriaga-Nava; S Iglesias-Gonzalez; P Gutierrez; C Ibarra-Perez; A Martinez; S Valencia; A Rosado-Buzzo; J A Pierzo; E Rosas
Journal:  J Thromb Thrombolysis       Date:  2001-12       Impact factor: 2.300
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.